zzzProgram – Test – Layout with Tablebuilder and Tabs Responsive





Main program

Saturday 24 October
1000 - 1130Plenary session 1: Management of rheumatic diseases during the COVID-19 pandemic

COVID-19 in rheumatology practice in Japan
Tsutomu Takeuchi, Keio University School of Medicine, Japan


1130 - 1245Morning symposium 1

"Beyond remission” based on patients’ subjective experiences for improved RA control

Morning symposium 2

Morning symposium 3

New evidence on the JAK inhibitor and its clinical implications for rheumatoid arthritis

Morning symposium 4
Brought to you by Brought to you by Brought to you by
1245 - 1315Break
1315 - 1445
Lunch symposium 1

Prospects for JAK inhibitors in the treatment of rheumatoid arthritis

Lunch symposium 2

Basic and Clinical of Rheumatology

Brought to you by
Brought to you by
1500 - 1640SpA - 1: New advances in Axial
SLE - 1: Progress and perspectives on SLE in the APLAR regionImaging: Imaging in rheumatic diseases - where do we standTreating children with rheumatic diseases in Asia Pacific: The Great Divide
Mitsumasa Kishimoto
Katy Leung
Nazrul Islam
Sandra Navarra
Yoshiya Tanaka
Chi-Chen Chang
Ved Chaturvedi
Masaki Mori
Surjit Singh
Outcome of Juvenile spondyloarthropathy in adulthood
Amita Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India
Patient education as vital to improving outcomes
Laniyati Hamijoyo, University of Padjadjaran, Indonesia
Ultrasound and its clinical use in rheumatoid arthritis
Kei Ikeda, Chiba University Hospital, Japan
Asia-Pacific Pediatric Rheumatology: Where Do We Stand
Sumaira Farman, National Hospital & Medical Center; Al-Aleem Medical College; Fatima Jinnah Medical University, Pakistan
Improving Access to Care in Resource Challenged Settings: Lessons from the Paediatric Task Force Global MSK Health
Helen Foster, Newcastle University, United Kingdom
Treat-to-Target in SpA, how far are we going?
James Wei, Chung Shan Medical University Hospital, Taiwan
Progress and Perspectives on SLE in the APLAR region
Evan Vista, St. Luke's Medical Center and College of Medicine, Philippines
Ultrasound in large vessel vasculitis
Kuo-Lung Lai, Taichung Veterans General Hospital, Taiwan
JIA: Geographic variability in treatment and long-term outcomes of JIA
Soamarat Vilaiyuk, Mahidol University, Thailand
When and how to use, or not to use MRI in SpA”
Ashish Jacob Mathew, Christian Medical College, India
Interim report of the APLAR consensus statements on the management of SLE
Chi Chiu Mok, Tuen Mun Hospital, Hong Kong
MRI in Rheumatoid Arthritis
Mami Tamai, Nagasaki University, Japan
Macrophage Activation Syndrome: Analysis of various Cytokines
Masaki Shimizu, Tokyo Medcial And Dental University, Japan
Novel assessment tool for bony damage in spondyloarthritis
Lai-shan Tam, The Chinese University of Hong Kong, Hong Kong
Ultrasound and its clinical use in spondyloarthropathy
Lee Ka Wing Gavin
Hong Kong
Autoinflammatory disorders: Spectrum seen in Asia Pacific
Sulaiman Al-Mayouf, King Faisal Specialist Hospital & Research Center, Saudi Arabia
Updates on the Asia Pacific Lupus Collaboration (APLC) cohort
Eric Morand, Australia
Vasculitis: Childhood onset Takayasu arteritis: an update
Satish Kumar, Christian Medical College, India
Panel Q&APanel Q&APanel Q&APanel Q&A
1640 - 1740Abstract session: IgG4-RD, AOSD/sJIA, Kawasaki diseaseAbstract session: SLE and APL syndrome 1Abstract session: IIM, SSc, SjSAbstract session: COVID-19 and CTD
Increased Human Neutrophil Lipocalin and its Clinical Relevance in Adult-Onset Still's Disease
Ji Li, Peking University International Hospital, China
Platelet Indices Could Be Simple, Reliable Predictors of Thrombotic Events in Patients with Antiphospholipid Syndrome
Yu Shi, Peking Union Medical College, China
Clinical and swallowing outcomes in patients with dermatomyositis and polymyositis with dysphagia using the Food Intake LEVEL Scale
Shin-ichiro Ohmura, Seirei Hamamatsu General Hospital, Japan
Rheumatic diseases on COVID-19 era
Selma Abdellaoui, Beni Messous Hospital, Algeria
Different Immunophenotypes Characterized IgG4-Related Disease Clinical Phenotypes
Eduardo Martín-Nares, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Mexico
Prevalence of celiac disease in patients with systemic lupus erythematosus
Zahra Soltani, Tehran University of Medical Sciences, Iran
Immunomodulatory Therapy: a New Strategy for Dermatomyositis /Polymyositis
Shengxiao Zhang, The Second Hospital of Shanxi Medical University, China
Prevalence of emotional disorder and sleep quality in patients with systemic lupus erythematosus during COVID-19 epidemic: a cross-sectional study
Jing Zhu, Sichuan Provincial People’s Hospital, China
Abnormality of peripheral lymphocyte subsets in patients with Bechet’s disease and their restorations after receiving new immunomodulatory therapy
Shengxiao Zhang, The Second Hospital of Shanxi Medical University, China
SLE Disease Activity Score (SLE-DAS) is a comparable disease activity measure to SLEDAI-2K
Masanori Kono, University of Tokyo Hospital, Japan
Characteristics And Outcomes Of Overlap Myositis: A Comparative Multigroup Study In Adults And Children with Idiopathic Inflammatory Myopathies (IIM)
Naveen R, Sanjay Gandhi Post Graduate Institute Of Medical Sciences, India
Factors associated with use of telemedicine for follow-up of lupus nepthritis in the COVID-19 outbreak
Ho So, The Chinese University of Hong Kong, Hong Kong
Application Of Preliminary PRINTO Classification Criteria For SJIA In An Indian Cohort
Devang Pandya, Dev Children's Hospital, India
Development of a genetic risk score for Filipino patients with systemic lupus erythematosus
Michael Tee, University of The Philippines, Philippines
Prognosis and Treatments of Patients with Myositis-associated Severe Interstitial Lung Disease: A Descriptive Study using National Inpatient Database in Japan
Hiroki Furuya, Department of Allergy And Clinical Immunology, Japan
Spectrum Of Systemic Inflammatory Syndrome In Children During COVID 19 Pandemic In India
Devang Pandya, Dev Children's Hospital, India
Long-term outcome of 21 cases of giant coronary aneurysm after Kawasaki disease - Our 40 years' experience
Tomomi Sato, Shiga University of Medical Science, Japan
The Association between Serum Leptin Levels, Body Mass Index, and Disease Activity in Women with Systemic Lupus Erythematosus
Nittayawadee Aeamsaard, Phramongkutklao Hospital and College of Medicine, Thailand
Nailfold Capillary Changes in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
Tomohiro Sugimoto, Hiroshima University Hospital, Japan
Reactive arthritis after COVID-19 infection
Keisuke Ono, Kyorin University School of Medicine, Japan
Immunophenotypic analysis of peripheral blood mononuclear cells in IgG4-Related Disease
Aya Nishiwaki, The University of Tokyo, Japan
Joint Q&AIs Rituximab an Adequate Glucocorticoid-Sparing Agent in Idiopathic Inflammatory Myopathies?
Serdal Ugurlu, Istanbul University- Cerrahpasa, Turkey
A Healthy Dose of Skepticism: Eosinophilic Granulomatosis with Polyangiitis Initially Presenting as Possible COVID-19
Vincent Anthony Tang, University Of The Philippines - Philippine General Hospital, Philippines
TBAJoint Q&AAssessing the Impact on Heath Seeking Behavior During COVID-19 Outbreak in a Group of Rheumatology Patients from Sri Lanka
Sunith Atukorale, Ministry of Health, Sri Lanka
Joint Q&AJoint Q&A
1740 - 1840Evening symposium 1

Evening symposium 2

Treat-to-target in SLE: addressing short- and long-term treatment goals

Evening symposium 3

ILD in Focus: Time to prioritize the lung in CTDs
Evening symposium 4

Perspectives around the accumulated evidence for IL-6 in autoimmune disease
Brought to you by Brought to you by Brought to you by Brought to you by
Sunday 25 October
1000 - 1130Plenary session 2: Past, present and future of rheumatology

Rheumatology: A Crystal Gaze? - a future perspective
Syed Haq, BSM Medical University, Bangladesh


Title TBA
Ian McInnes, University of Glasgow, United Kingdom
1130 - 1245Morning symposium 5

Treatment of Rheumatoid Arthritis: Past and Future

Morning symposium 6

To continue, taper or discontinue biologics – Implications on RA treatment outcomes

Morning symposium 7Morning symposium 8
Brought to you by Brought to you by
1245 - 1315Break
1315 - 1445
Lunch symposium 3
New insights for clinical practice in Spondyloarthritis, SpA

Brought to you by
Lunch symposium 4

New therapeutic alternatives for rheumatic diseases: Individualizing the treatment approach

Brought to you by
1500 - 1640Vasculitis: Merge of basic and clinical researches of vasculitisSLE - 2: SLE clinicalGenetics: recent progress in genetics of rheumatic diseasesSpA - 2: Updates in PsA
Debashish Danda
Xinping Tian
Masayoshi Harigai
Yoshiya Tanaka
Michael Tee
Zhanghou Li
Atimichi Morita
James Wei
TBAManagement of systemic lupus erythematosus (SLE) during and beyond the COVID-19 pandemic
Sandra V. Navarra, University of Santo Tomas, Philippines
GWAS, eQTL and epigenome of rheumatic diseases
Kazuhiko Yamamoto, RIKEN Center for Integrative Medical Sciences, Japan
Differential diagnosis of Psoriatic arthritis in daily practice
Mitsumasa Kishimoto, Kyorin University School of Medicine, Japan
Genetic analysis of Takayasu arteritis
Ruchika Goel, Christian Medical College, India
Risk assessment and prevention of cardiovascular co-morbidities in psoriatic arthritis
Lai-Shan Tam, The Chinese University of Hong Kong, Hong Kong
TBAContinuing challenges in lupus nephritis
Daniel TM Chan, University of Hong Kong, Hong Kong
Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population
Jianping Guo, Peking University People's Hospital, China
Panel Q&A
TBASpecial issues on pregnancy and lactation
Aisha Lateef, Woodlands Health Campus, Singapore
Genetics of Kawasaki Disease: where are we in circa 2020
Surjit Singh, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education And Research, Chandigarh, India
Biomarker for PsA – myth or reality
Katy Leung, Singapore General Hospital, Duke-nus Medical School, Singapore
TBAGenetic risk score
Sarah Reid
Panel Q&APanel Q&APanel Q&A
1640 - 1740Abstract session: IIM, SSc, SjSAbstract session: SLE and APL syndrome 2Abstract session: OA and Crystal induced arthritisAbstract session: SpA, AS-1
Clinical Responses to Low-dose Interleukin-2 in Idiopathic Inflammatory Myopathies
Miao Miao, Peking University People's Hospital, China
Leukocyte immunoglobulin-like receptor A3 (LILRA3) promotes lupus-like disease severity
Yundi Tang, Peking University People's Hospital, China
The numeral changes of peripheral lymphocyte subsets in 238 patients with GOUT and their correlation analysis with disease activity
Lijun Zhao, The Second Hospital of Shanxi Medical University, China
Prediction of myocardial abnormalities in systemic sclerosis, assessed in cardiac magnetic resonance imaging, by using artificial neural networks models
Masaki Haraoka, St. Marianna University School of Medicine, Japan
Should ophthalmologic evaluation be done as a screening test for new onset lupus patients with no eye complaint?
Seyedeh Tahereh Faezi, Tehran University of Medical Sciences, Iran
Subtype Genome-Wide Meta-Analyses of Clinically-Defined Gout Revealed Multiple Subtype-Specific Gout Loci and Enrichment of Selection Pressure on ABCG2 and ALDH2
Yusuke Kawamura, National Defense Medical College, Japan
Efficacy and Safety of Brodalumab, Anti-IL-17 Receptor A Monoclonal Antibody, for Axial Spondyloarthritis, A 68-Week Result of Phase 3 Study
Tae-Hwan Kim, Hanyang University Medical Center, Democratic Republic of Korea
Clinical analysis of dermatomyositis / polymyositis / cancer-associated myositis and related research on peripheral blood CD4 + T lymphocyte subsets
Pan-di Zhang, The Second Hospital of Shanxi Medical University, China
TBASystematic Review and Meta-Analysis of the Prevalence of Neuropathic-Like Pain and Pain Sensitisation in People With Knee and Hip Osteoarthritis
Luigi Zolio, Alfred Health, Australia
Improvements in Patient-Reported Outcomes in AS Patients Treated With Golimumab: Sub-Analysis of Asian Patients Enrolled in Phase III Clinical Trials
Wen-Chan Tsai, Kaohsiung Medical University, Taiwan
Diagnostic Accuracy of Salivary Free Light Chain and Immunoglobulin Assays in Primary Sjögren's Syndrome
Pulukool Sandhya, St Stephens Hospital Delhi, India
Voclosporin Has Demonstrated Efficacy in Asian Patients With Lupus Nephritis
Tatsuya Atsumi, Hokkaido University, Japan
A Randomised Placebo-controlled Clinical Trial of Curcuma Longa Extract for Treating Symptoms and Effusion-synovitis of Knee Osteoarthritis (CurKOA trial)
Benny Samuel Eathakkattu Antony, University of Tasmania, Australia
Abnormality of peripheral lymphocyte subsets in patients with ankylosing spondylitis and restoration after receiving immunoregulatory combination therapies
Shengxiao Zhang, The Second Hospital of Shanxi Medical University, China
The Artificial Intelligence for the Prediction of Focal Score of Labial Salivary Gland Biopsy in the Diagnosis of Sjogren Syndrome
Nobooru Kitamura, Nihon University School of Medicine, Japan
Newly Diagnosed Lupus Nephritis in Elderly Predicts Good Renal Outcome: a Distinct Disease Subset from Young-onset Lupus Nephritis
Kazuoto Hiramoto, Keio University School of Medicine, Japan
The Trajectory of Exercise Adherence Over Time and the Effect of Theory-lead Intervention for Knee Osteoarthritis in Elderly
Limin Wang, Peking University, China
Comorbidity Profiles among patients with Axial Spondyloarthritis
Fariz Yahya
Effects of Nintedanib in Asian Patients with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD): Subgroup Analysis of the SENSCIS Trial
Masataka Kuwana, Nippon Medical School, Japan
Thrombotic risk assessment in patient with systemic lupus erythematosus: validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients
Wanitcha Chanloung, Chiang Mai University, Thailand
The Prevalence and Incidence of Symptom Knee Osteoarthritis in the Middle-aged and Elderly: a National Survey from China
Limin Wang, Peking University, China
Response to Certolizumab Pegol in Patients with Non-Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Cut-Offs: Post-Hoc Analysis from C-axSpAnd
Philip Robinson, University of Queensland, Australia
Joint Q&ASerological Evolution in Patients with Positive Antiphospholipid Antibodies-A Retrospective Study of Chinese Cohort
Lanlan Ji, Peking University First Hospital, China
Prevalence and Clinical Features of Early-onset Osteoarthritis in a Large Scale Cross-sectional Study
Jiajing Peng, Peking University People’s Hospital, China
Imbalance of Th17/Treg In Cardiovascular Diseases of Patients With Ankylosing Spondylitis
Tingting Ding, The Second Hospital of Shanxi Medical University, China
Joint Q&AJoint Q&AJoint Q&A
1740 - 1840Evening symposium 5

Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient

Evening symposium 6

The role of interleukin-6 in rheumatoid arthritis

Evening symposium 7

Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies

Evening symposium 8

Brought to you by
Brought to you by
Brought to you by